176
Views
18
CrossRef citations to date
0
Altmetric
Reviews

The role of vaccine therapy in the treatment of melanoma

, MD PhD FRCS
Pages 315-323 | Published online: 25 Feb 2008

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Sara Tomei, Ena Wang, Lucia Gemma Delogu, Francesco M Marincola & Davide Bedognetti. (2014) Non-BRAF-targeted therapy, immunotherapy, and combination therapy for melanoma. Expert Opinion on Biological Therapy 14:5, pages 663-686.
Read now
Theresa L Whiteside. (2010) Inhibiting the inhibitors: evaluating agents targeting cancer immunosuppression. Expert Opinion on Biological Therapy 10:7, pages 1019-1035.
Read now
Lee B Riley & Sanjiv S Agarwala. (2008) Melanoma vaccines. Expert Review of Vaccines 7:7, pages 937-949.
Read now

Articles from other publishers (15)

Cheorl-Ho KimCheorl-Ho Kim. 2020. Ganglioside Biochemistry. Ganglioside Biochemistry 193 214 .
Amene Saghazadeh & Nima Rezaei. 2020. Cancer Immunology. Cancer Immunology 305 332 .
Alexandra M. Haugh & Douglas B. Johnson. (2019) Management of V600E and V600K BRAF-Mutant Melanoma. Current Treatment Options in Oncology 20:11.
Crossref
Ke-Hua Li, Thomas Griffin, Neda Nikbakht, Le Qu, Hong-Duo Chen, Chundi He & Li-Xin Xia. 2017. Practical Immunodermatology. Practical Immunodermatology 279 296 .
Ryan J. Davey, Andre van der Westhuizen & Nikola A. Bowden. (2016) Metastatic melanoma treatment: Combining old and new therapies. Critical Reviews in Oncology/Hematology 98, pages 242-253.
Crossref
Martin J. D’Souza, Rikhav P. Gala, Ruhi V. Ubale, Bernadette D’Souza, Trinh Phuong Vo, Ashwin C. Parenky, Nihal S. Mulla, Sucheta D’Sa, Marissa D’Souza, Kim Braz-Gomes, Nigel D’Souza, Maurizio Chiriva-Internati & Susu Zughaier. 2015. Novel Approaches and Strategies for Biologics, Vaccines and Cancer Therapies. Novel Approaches and Strategies for Biologics, Vaccines and Cancer Therapies 89 122 .
Ravi A. Madan, Theresa A. Ferrara & James L. Gulley. 2014. Handbook of Anticancer Pharmacokinetics and Pharmacodynamics. Handbook of Anticancer Pharmacokinetics and Pharmacodynamics 553 568 .
Han-fang Mei, Xiao-bao Jin, Jia-yong Zhu, Ai-hua Zeng, Qiang Wu, Xue-mei Lu, Xiao-bo Li & Juan Shen. (2012) ?-defensin 2 as an Adjuvant Promotes Anti-Melanoma Immune Responses and Inhibits the Growth of Implanted Murine Melanoma In Vivo. PLoS ONE 7:2, pages e31328.
Crossref
Matthew T. Ballo & K. Kian Ang. 2012. Clinical Radiation Oncology. Clinical Radiation Oncology 771 782 .
Katharina Amschler, Michael P. Schön, Nadin Pletz, Katrin Wallbrecht, Luise Erpenbeck & Margarete Schön. (2010) NF-κB Inhibition through Proteasome Inhibition or IKKβ Blockade Increases the Susceptibility of Melanoma Cells to Cytostatic Treatment through Distinct Pathways. Journal of Investigative Dermatology 130:4, pages 1073-1086.
Crossref
Alexander M.M. Eggermont. (2009) Immunostimulation Versus Immunosuppression after Multiple Vaccinations: the Woes of Therapeutic Vaccine Development. Clinical Cancer Research 15:22, pages 6745-6747.
Crossref
Ji-Wei Liu, Ping Sun, Qiu Yan, Amy S. Paller, Pedram Gerami, Nancy Ho, Neelam Vashi, I. Caroline Le Poole & Xiao-qi Wang. (2009) De- N -acetyl GM3 Promotes Melanoma Cell Migration and Invasion through Urokinase Plasminogen Activator Receptor Signaling–Dependent MMP-2 Activation . Cancer Research 69:22, pages 8662-8669.
Crossref
D. Schadendorf, S.M. Algarra, L. Bastholt, G. Cinat, B. Dreno, A.M.M. Eggermont, E. Espinosa, J. Guo, A. Hauschild, T. Petrella, J. Schachter & P. Hersey. (2009) Immunotherapy of distant metastatic disease. Annals of Oncology 20, pages vi41-vi50.
Crossref
Alexander M.M. Eggermont. (2009) Therapeutic vaccines in solid tumours: Can they be harmful?. European Journal of Cancer 45:12, pages 2087-2090.
Crossref
Aude Bonehill, An M.T. Van Nuffel, Jurgen Corthals, Sandra Tuyaerts, Carlo Heirman, Violaine François, Didier Colau, Pierre van der Bruggen, Bart Neyns & Kris Thielemans. (2009) Single-Step Antigen Loading and Activation of Dendritic Cells by mRNA Electroporation for the Purpose of Therapeutic Vaccination in Melanoma Patients. Clinical Cancer Research 15:10, pages 3366-3375.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.